• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[持续皮下胰岛素输注治疗胰岛素依赖型糖尿病]

[Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus].

作者信息

Gröbe H, Seibold H, Ullrich K, Müller-Limmroth S, Ziegler R

机构信息

Städtische Kinderklinik, Nürnberg.

出版信息

Monatsschr Kinderheilkd. 1988 Feb;136(2):81-4.

PMID:3367913
Abstract

Intensified insulin delivery has attained significant importance in the treatment of insulin-dependent diabetes to avoid microangiopathy involving the retina and kidney. 15 patients have been treated for periods from 2 month to 3 years, 2 years with continuous subcutaneous insulin infusion. All patients have better metabolic control than that achieved with conventional therapy. HbA1c decreased from 7.8% +/- 1.6 (SD) to 6.2% +/- 1.3 (normal value: 3.8-6.5%). Negative features of insulin-pump therapy include hyperglycemias after discontinuation of insulin infusion and cutaneous infection at the catheter site. No severe episodes of hypoglycemia were observed. Acceptability of pump treatment is good in our patients because of improved physical condition and the ability to pursue their usual activities.

摘要

强化胰岛素给药在胰岛素依赖型糖尿病的治疗中已变得极为重要,以避免涉及视网膜和肾脏的微血管病变。15名患者接受了2个月至3年的治疗,其中2年采用持续皮下胰岛素输注。所有患者的代谢控制情况均优于传统疗法。糖化血红蛋白(HbA1c)从7.8%±1.6(标准差)降至6.2%±1.3(正常值:3.8 - 6.5%)。胰岛素泵治疗的负面特征包括停止胰岛素输注后的高血糖症以及导管部位的皮肤感染。未观察到严重低血糖发作。由于身体状况改善以及能够进行日常活动,我们的患者对泵治疗的接受度良好。

相似文献

1
[Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus].[持续皮下胰岛素输注治疗胰岛素依赖型糖尿病]
Monatsschr Kinderheilkd. 1988 Feb;136(2):81-4.
2
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.接受持续皮下胰岛素输注治疗的意大利糖尿病患者的代谢控制与并发症
Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):335-342. doi: 10.1016/j.numecd.2017.12.001. Epub 2017 Dec 9.
3
[The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].[持续皮下胰岛素输注长期使用对1型糖尿病控制的影响]
Acta Med Port. 2019 Feb 1;32(1):17-24. doi: 10.20344/amp.10778.
4
[Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
Med Klin (Munich). 1988 May 27;83(12):398-401.
5
Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.接受胰岛素泵治疗并辅以连续血糖监测的糖尿病患者的斋月禁食:一项观察性真实世界研究。
Diabetes Technol Ther. 2012 Sep;14(9):813-8. doi: 10.1089/dia.2012.0061. Epub 2012 Jul 24.
6
Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.糖尿病儿童和青少年持续皮下胰岛素输注:糖化血红蛋白降低且低血糖风险低。
J Pediatr Endocrinol Metab. 2003 Mar;16(3):393-9. doi: 10.1515/jpem.2003.16.3.393.
7
Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.用于评估连续血糖监测系统中葡萄糖变异性的庞加莱图量化方法及一种新的低血糖风险标志物:在转换为持续皮下胰岛素输注的1型糖尿病患者中的应用
Diabetes Technol Ther. 2014 Apr;16(4):247-54. doi: 10.1089/dia.2013.0241. Epub 2013 Nov 15.
8
Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.在接受多次每日注射与持续皮下胰岛素输注治疗的1型糖尿病儿童和青少年中,通过持续皮下葡萄糖传感检测到的血糖模式。
Arch Pediatr Adolesc Med. 2004 Jul;158(7):677-84. doi: 10.1001/archpedi.158.7.677.
9
Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?1 型糖尿病发病后起始胰岛素泵治疗的时机是否会对血糖控制产生影响?
Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.
10
Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.意大利两种不同1型糖尿病患者群体中传感器增强泵治疗的成本效益
Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):707-715. doi: 10.1016/j.numecd.2018.03.011. Epub 2018 Apr 5.